Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026)
Zentalis Pharmaceuticals' (ZNTL) quarterly EPS (Basic) came in at -$0.5 in Q1 2026, up 25.3% year-on-year from -$0.4 in Q1 2025, and down 2.68% quarter-over-quarter from -$0.49 in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) EPS (Basic) (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.5 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 25.3% year-over-year to -$0.5 in Q1 2026; TTM through Mar 2026 was -$1.77, a 43.52% increase from a year earlier, with the FY2025 full-year figure at -$1.91, up 18.27% from the prior year.
- EPS (Basic) eased to -$0.5 in Q1 2026 per ZNTL's latest filing, from -$0.49 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.14 in Q1 2024 and bottomed at -$1.63 in Q2 2023.
- The 5-year median for EPS (Basic) is -$0.79 (2023), against an average of -$0.79.
- Across the five-year window, EPS (Basic) jumped 113.77% in 2024 and plunged 575.63% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.91 in 2022, then slipped by 2.25% to -$0.93 in 2023, then rose by 28.31% to -$0.67 in 2024, then grew by 26.63% to -$0.49 in 2025, then slipped by 2.68% to -$0.5 in 2026.
- Per Business Quant, the three latest ZNTL EPS (Basic) figures stand at -$0.5 (Q1 2026), -$0.49 (Q4 2025), and -$0.37 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - | -0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.50 |
| Dec 31, 2025 | -0.49 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -1.24 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | -0.93 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | -1.63 |
| Mar 31, 2023 | -1.03 |
| Dec 31, 2022 | -0.91 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -1.23 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | -1.13 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -1.35 |